Quarterly Financial Data (Unaudited) (Restated) (Tables)

12 Months Ended

Dec. 31, 2020

Quarterly Financial Information Disclosure [Abstract]

Schedule of balance sheets

	As Previously					As
	Reported		Adjustments			Restated
Assets
Cash	$	296,759	$	-		$	296,759
Prepaid assets		7,415		-			7,415
Total Current Assets		304,174		-			304,174
							-
Cash and investments held in Trust Account		116,012,861		-			116,012,861
Total Assets	$	116,317,035	$	-		$	116,317,035
Liabilities, Temporary Equity, and Shareholders’ Equity (Deficit)
Accounts payable and accrued expenses	$	4,069	$	-		$	4,069
Promissory note - related party		300,000		-			300,000
Total Current Liabilities		304,069		-			304,069
Warrants liabilities		585,321		-			585,321
Deferred underwriting compensation		4,020,797		-			4,020,797
Total Liabilities		4,910,187		-			4,910,187
Commitments and Contingencies
Ordinary shares subject to possible redemption, 10,535,331 and 11,487,992 shares as previously reported and as restated, respectively, at conversion value of $10.10 per share		106,406,842		9,606,019			116,012,861
Shareholders’ Equity (Deficit):
Preference shares, no par value, 100,000,000 shares authorized, none issued and outstanding		-		-			-
Ordinary shares, no par value; 300,000,000 shares authorized; 4,154,419 and 3,201,758 shares (excluding 10,535,331 and 11,487,992 shares subject to possible redemption) as previously reported and as restated, respectively		4,043,035		(4,043,035	)		-
Retained earnings (accumulated deficit)		956,971		(5,562,984	)		(4,606,013	)
Total Shareholders’ Equity (Deficit)		5,000,006		(9,606,019	)		(4,606,013	)
Total Liabilities, Temporary Equity, and Shareholders’ Equity (Deficit)	$	116,317,035	$	-		$	116,317,035

	As Previously					As
	Reported		Adjustments			Restated
Assets
Cash	$	165,890	$	-		$	165,890
Prepaid assets		1,651		-			1,651
Total Current Assets		167,541		-			167,541
							-
Cash and investments held in Trust Account		116,706,912		-			116,706,912
Total Assets	$	116,874,453	$	-		$	116,874,453
Liabilities, Temporary Equity, and Shareholders’ Equity (Deficit)
Accounts payable and accrued expenses	$	4,272	$	-		$	4,272
Promissory note - related party		300,000		-			300,000
Total Current Liabilities		304,272		-			304,272
Warrants liabilities		568,672		-			568,672
Deferred underwriting compensation		4,020,797		-			4,020,797
Total Liabilities		4,893,741		-			4,893,741
Commitments and Contingencies
Ordinary shares subject to possible redemption, 10,529,597 and 11,487,992 shares as previously reported and as restated, respectively, at conversion value of $10.16 per share		106,980,704		9,726,208			116,706,912
Shareholders’ Equity (Deficit):
Preference shares no par value, 100,000,000 shares authorized, none issued and outstanding		-		-			-
Ordinary shares, no par value; 300,000,000 shares authorized; 4,160,153 and 3,201,758 shares (excluding 10,529,597 and 11,487,992 shares subject to possible redemption) as previously reported and as restated, respectively		3,469,173		(3,469,173	)		-
Retained earnings (accumulated deficit)		1,530,835		(6,257,035	)		(4,726,200	)
Total Shareholders’ Equity (Deficit)		5,000,008		(9,726,208	)		(4,726,200	)
Total Liabilities, Temporary Equity, and Shareholders’ Equity (Deficit)	$	116,874,453	$	-		$	116,874,453

	As Previously					As
	Reported		Adjustments			Restated
Assets
Cash	$	1,237,095	$	-		$	1,237,095
Total Current Assets		1,237,095		-			1,237,095
							-
Cash and investments held in Trust Account		117,324,145		-			117,324,145
Total Assets	$	118,561,240	$	-		$	118,561,240
Liabilities, Temporary Equity, and Shareholders’ Equity (Deficit):
Accounts payable and accrued expenses	$	5,675	$	-		$	5,675
Promissory note		1,148,800		-			1,148,800
Promissory note - related party		300,000		-			300,000
Total Current Liabilities		1,454,475		-			1,454,475
Warrants liabilities		548,309		-			548,309
Deferred underwriting compensation		4,020,797		-			4,020,797
Total Liabilities		6,023,581		-			6,023,581
Commitments and Contingencies
Ordinary shares subject to possible redemption, 10,532,581 and 11,487,992 shares as previously reported and as restated, respectively, at conversion value of $10.21 per share		107,537,651		9,786,494			117,324,145
Shareholders’ Equity (Deficit):
Preference shares, no par value, 100,000,000 shares authorized, none issued and outstanding		-		-			-
Ordinary shares, no par value; 300,000,000 shares authorized; 4,157,169 and 3,201,758 shares (excluding 10,532,581 and 11,487,992 shares subject to possible redemption) as previously reported and as restated, respectively		2,912,226		(2,912,226	)		-
Retained earnings (accumulated deficit)		2,087,782		(6,874,268	)		(4,786,486	)
Total Shareholders’ Equity (Deficit)		5,000,008		(9,786,494	)		(4,786,486	)
Total Liabilities, Temporary Equity, and Shareholders’ Equity (Deficit)	$	118,561,240	$	-		$	118,561,240

	As Previously					As
	Reported		Adjustments			Restated
Assets
Cash	$	11,178	$	-		$	11,178
Prepaid assets		48,625		-			48,625
Total Current Assets		59,803		-			59,803
							-
Cash and investments held in Trust Account		120,728,495		-			120,728,495
Total Assets	$	120,788,298	$	-		$	120,788,298
Liabilities, Temporary Equity, and Shareholders’ Equity (Deficit)
Accounts payable and accrued expenses	$	105,043	$	-		$	105,043
Promissory note		1,648,800		-			1,648,800
Promissory note - related party		1,080,000		-			1,080,000
Total Current Liabilities		2,833,843		-			2,833,843
Warrants liabilities		516,901		-			516,901
Deferred underwriting compensation		4,020,797		-			4,020,797
Total Liabilities		7,371,541		-			7,371,541
Commitments and Contingencies
Ordinary shares subject to possible redemption, 10,315,581 and 11,487,992 shares as previously reported and as restated, respectively, at conversion value of $10.51 per share		108,416,755		12,311,740			120,728,495
Shareholders’ Equity (Deficit):
Preference shares, no par value, 100,000,000 shares authorized, none issued and outstanding		-		-			-
Ordinary shares, no par value; 300,000,000 shares authorized; 4,324,988 and 3,201,758 shares (excluding 10,315,581 and 11,487,992 shares subject to possible redemption) as previously reported and as restated, respectively		2,033,122		(2,033,122	)		-
Retained earnings (accumulated deficit)		2,966,880		(10,278,618	)		(7,311,738	)
Total Shareholders’ Equity (Deficit)		5,000,002		(12,311,740	)		(7,311,738	)
Total Liabilities, Temporary Equity, and Shareholders’ Equity (Deficit)	$	120,788,298	$	-		$	120,788,298

	As Previously					As
	Reported		Adjustments			Restated
Assets
Cash	$	9,289	$	-		$	9,289
Prepaid assets		36,010		-			36,010
Total Current Assets		45,299		-			45,299
							-
Cash and investments held in Trust Account		14,993,648		-			14,993,648
Total Assets	$	15,038,947	$	-		$	15,038,947
Liabilities, Temporary Equity,  and Shareholders’ Equity (Deficit)
Accounts payable and accrued expenses	$	156,574	$	-		$	156,574
Due to related party		100,005		-			100,005
Promissory note		1,748,800		-			1,748,800
Promissory note - related party		1,080,000		-			1,080,000
Total Current Liabilities		3,085,379		-			3,085,379
Warrants liabilities		510,839		-			510,839
Deferred underwriting compensation		4,020,797		-			4,020,797
Total Liabilities		7,617,015		-			7,617,015
Commitments and Contingencies
Ordinary shares subject to possible redemption, 228,484 and 1,414,480 shares as previously reported and as restated, respectively, at conversion value of $10.60 per share		2,421,929		12,571,719			14,993,648
Shareholders’ Equity (Deficit):
Preference shares, no par value, 100,000,000 shares authorized, none issued and outstanding		-		-			-
Ordinary shares, no par value; 300,000,000 shares authorized; 4,387,754 and 3,201,758 shares (excluding 228,484 and 1,414,480 shares subject to possible redemption) as previously reported and as restated, respectively		2,148,830		(2,148,830	)		-
Retained earnings (accumulated deficit)		2,851,173		(10,422,889	)		(7,571,716	)
Total Shareholders’ Equity (Deficit)		5,000,003		(12,571,719	)		(7,571,716	)
Total Liabilities, Temporary Equity,  and Shareholders’ Equity (Deficit)	$	15,038,947	$	-		$	15,038,947

	As Previously					As
	Reported		Adjustments			Restated
Assets
Cash	$	1,595	$	-		$	1,595
Prepaid assets		19,385		-			19,385
Total Current Assets		20,980		-			20,980
							-
Cash and investments held in Trust Account		15,174,028		-			15,174,028
Total Assets	$	15,195,008	$	-		$	15,195,008
Liabilities, Temporary Equity, and Shareholders’ Equity (Deficit)
Accounts payable and accrued expenses	$	187,604	$	-		$	187,604
Due to related party		205,000		-			205,000
Promissory notes		1,868,800		-			1,868,800
Promissory note - related party		1,080,000		-			1,080,000
Total Current Liabilities		3,341,404		-			3,341,404
Warrants liabilities		495,105		-			495,105
Deferred underwriting compensation		4,020,797		-			4,020,797
Total Liabilities		7,857,306		-			7,857,306
Commitments and Contingencies
Ordinary shares subject to possible redemption, 217,866 and 1,414,480 shares as previously reported and as restated, respectively, at conversion value of $10.73 per share		2,337,698		12,836,330			15,174,028
Shareholders’ Equity (Deficit):
Preference shares, no par value, 100,000,000 shares authorized, none issued and outstanding		-		-			-
Ordinary shares, no par value; 300,000,000 shares authorized; 4,398,372 and 3,201,758 shares (excluding 217,866 and 1,414,480 shares subject to possible redemption) as previously reported and as restated, respectively		2,233,061		(2,233,061	)		-
Retained earnings (accumulated deficit)		2,766,943		(10,603,269	)		(7,836,326	)
Total Shareholders’ Equity (Deficit)		5,000,004		(12,836,330	)		(7,836,326	)
Total Liabilities, Temporary Equity, and Shareholders’ Equity (Deficit)	$	15,195,008	$	-		$	15,195,008

Schedule of statements of operations

	Three Months Ended March 31, 2019
	As Previously						As
	Reported			Adjustments			Restated
Operating costs	$	153,741		$	-		$	153,741
Loss from operations		(153,741	)		-			(153,741	)
Other income:
Interest income - bank		143			-			143
Interest income		688,610			-			688,610
Change in fair value of warrant liabilities		25,857			-			25,857
Total other income		714,610			-			714,610
Net income	$	560,869		$	-		$	560,869
Less: income attributable to ordinary shares subject to possible redemption		(631,524	)		631,524			-
Adjusted net loss	$	(70,655	)	$	70,655		$	-
Basic and diluted weighted average redeemable ordinary shares outstanding		-			11,487,992			11,487,992
Basic and diluted net loss per redeemable ordinary share	$	-		$	(0.01	)	$	(0.01	)
Basic and diluted weighted average non-redeemable ordinary shares outstanding		4,147,322			(945,564	)		3,201,758
Basic and diluted net loss per non-redeemable ordinary share	$	(0.02	)	$	0.01		$	(0.01	)

	Three Months Ended June 30, 2019									Six Months Ended June 30, 2019
	As Previously						As			As Previously						As
	Reported			Adjustments			Restated			Reported			Adjustments			Restated
Operating costs	$	137,145		$	-		$	137,145		$	290,886		$	-		$	290,886
Loss from operations		(137,145	)		-			(137,145	)		(290,886	)		-			(290,886	)
Other income:
Interest income - bank		309			-			309			452			-			452
Interest income		694,051			-			694,051			1,382,661			-			1,382,661
Change in fair value of warrant liabilities		16,649			-			16,649			42,506			-			42,506
Total other income		711,009			-			711,009			1,425,619			-			1,425,619
Net income	$	573,864		$	-		$	573,864		$	1,134,733		$	-		$	1,134,733
Less: income attributable to ordinary shares subject to possible redemption		(636,167	)		636,167			-			(1,267,347	)		1,267,347			-
Adjusted net loss	$	(62,303	)	$	62,303		$	-		$	(132,614	)	$	132,614		$	-
Basic and diluted weighted average redeemable ordinary shares outstanding		-			11,487,992			11,487,992			-			11,487,992			11,487,992
Basic and diluted net loss per redeemable ordinary share	$	-		$	(0.01	)	$	(0.01	)	$	-		$	(0.02	)	$	(0.02	)
Basic and diluted weighted average non-redeemable ordinary shares outstanding		4,154,419			(952,661	)		3,201,758			4,150,890			(949,132	)		3,201,758
Basic and diluted net loss per non-redeemable ordinary share	$	(0.01	)	$	0.00		$	(0.01	)	$	(0.03	)	$	0.01		$	(0.02	)

	Three Months Ended September 30, 2019									Nine Months Ended September 30, 2019
	As Previously						As			As Previously						As
	Reported			Adjustments			Restated			Reported			Adjustments			Restated
Operating costs	$	80,795		$	-		$	80,795		$	371,681		$	-		$	371,681
Loss from operations		(80,795	)		-			(80,795	)		(371,681	)		-			(371,681	)
Other income:
Interest income - bank		146			-			146			598			-			598
Interest income		617,233			-			617,233			1,999,894			-			1,999,894
Change in fair value of warrant liabilities		20,363			-			20,363			62,869			-			62,869
Total other income		637,742			-			637,742			2,063,361			-			2,063,361
Net income	$	556,947		$	-		$	556,947		$	1,691,680		$	-		$	1,691,680
Less: income attributable to ordinary shares subject to possible redemption		(565,879	)		565,879			-			(1,833,503	)		1,833,503			-
Adjusted net loss	$	(8,932	)	$	8,932		$	-		$	(141,823	)	$	141,823		$	-
Basic and diluted weighted average redeemable ordinary shares outstanding		-			11,487,992			11,487,992			-			11,487,992			11,487,992
Basic and diluted net loss per redeemable ordinary share	$	-		$	(0.00	)	$	(0.00	)	$	-		$	(0.02	)	$	(0.02	)
Basic and diluted weighted average non-redeemable ordinary shares outstanding		4,160,153			(958,395	)		3,201,758			4,153,521			(951,763	)		3,201,758
Basic and diluted net loss per non-redeemable ordinary share	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.03	)	$	0.01		$	(0.02	)

	Three Months Ended March 31, 2020
	As Previously						As
	Reported			Adjustments			Restated
Operating costs	$	149,055		$	-		$	149,055
Loss from operations		(149,055	)		-			(149,055	)
Other income:
Interest income - bank		827			-			827
Interest income		534,368			-			534,368
Change in fair value of warrant liabilities		16,418			-			16,418
Total other income		551,613			-			551,613
Net income	$	402,558		$	-		$	402,558
Less: income attributable to ordinary shares subject to possible redemption		(479,809	)		479,809			-
Adjusted net loss	$	(77,251	)	$	77,251		$	-
Basic and diluted weighted average redeemable ordinary shares outstanding		-			11,487,992			11,487,992
Basic and diluted net loss per redeemable ordinary share	$	-		$	(0.09	)	$	(0.09	)
Basic and diluted weighted average non-redeemable ordinary shares outstanding		4,263,670			(1,061,912	)		3,201,758
Basic and diluted net loss per non-redeemable ordinary share	$	(0.02	)	$	(0.07	)	$	(0.09	)

	Three Months Ended June 30, 2020									Six Months Ended June 30, 2020
	As Previously						As			As Previously						As
	Reported			Adjustments			Restated			Reported			Adjustments			Restated
Operating costs	$	146,045		$	-		$	146,045		$	295,100		$	-		$	295,100
Loss from operations		(146,045	)		-			(146,045	)		(295,100	)		-			(295,100	)
Other income:
Interest income - bank		5			-			5			832			-			832
Interest income		24,271			-			24,271			558,639			-			558,639
Change in fair value of warrant liabilities		6,062			-			6,062			22,480			-			22,480
Total other income		30,338			-			30,338			581,951			-			581,951
Net (loss) income	$	(115,707	)	$	-		$	(115,707	)	$	286,851		$	-		$	286,851
Less: income attributable to ordinary shares subject to possible redemption		(3,920	)		3,920			-			(90,220	)		90,220			-
Adjusted net loss	$	(119,627	)	$	119,627		$	-		$	196,631		$	(196,631	)	$	-
Basic and diluted weighted average redeemable ordinary shares outstanding		-			3,960,532			3,960,532			-			7,724,262			7,724,262
Basic and diluted net loss per redeemable ordinary share	$	-		$	(0.04	)	$	(0.04	)	$	-		$	(0.14	)	$	(0.14	)
Basic and diluted weighted average non-redeemable ordinary shares outstanding		4,374,169			(1,172,411	)		3,201,758			4,318,920			(1,117,162	)		3,201,758
Basic and diluted net loss per non-redeemable ordinary share	$	(0.03	)	$	(0.01	)	$	(0.04	)	$	0.05		$	(0.19	)	$	(0.14	)

	Three Months Ended September 30, 2020									Nine Months Ended September 30, 2020
	As Previously						As			As Previously						As
	Reported			Adjustments			Restated			Reported			Adjustments			Restated
Operating costs	$	100,347		$	-		$	100,347		$	395,447		$	-		$	395,447
Loss from operations		(100,347	)		-			(100,347	)		(395,447	)		-			(395,447	)
Other income:
Interest income - bank		3			-			3			835			-			835
Interest income		380			-			380			559,019			-			559,019
Change in fair value of warrant liabilities		15,734			-			15,734			38,214			-			38,214
Total other income		16,117			-			16,117			598,068			-			598,068
Net (loss) income		(84,230	)		-			(84,230	)		202,621			-			202,621
Less: income attributable to ordinary shares subject to possible redemption		(59	)		59			-			(86,089	)		86,089			-
Adjusted net (loss) income	$	(84,289	)	$	84,289		$	-		$	116,532		$	(116,532	)	$	-
Basic and diluted weighted average redeemable ordinary shares outstanding		-			1,414,480			1,414,480			-			5,605,649			5,605,649
Basic and diluted net loss per redeemable ordinary share	$	-		$	(0.06	)	$	(0.06	)	$	-		$	(0.20	)	$	(0.20	)
Basic and diluted weighted average non-redeemable ordinary shares outstanding		4,387,754			(1,185,996	)		3,201,758			4,340,885			(1,139,127	)		3,201,758
Basic and diluted net loss per non-redeemable ordinary share	$	(0.02	)	$	(0.04	)	$	(0.06	)	$	0.03		$	(0.23	)	$	(0.20	)

Schedule of statements of cash flows

	As Previously						As
	Reported			Adjustments			Restated
Cash Flows from Operating Activities:
Net income	$	560,869		$	-		$	560,869
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on investment held in Trust Account		(688,610	)		-			(688,610	)
Change in fair value of warrant liabilities		(25,857	)		-			(25,857	)
Changes in current assets and current liabilities:
Prepaid assets		6,347			-			6,347
Accounts payable and accrued expense		(6,020	)		-			(6,020	)
Due to related parties		(2,379	)		-			(2,379	)
Net Cash Used in Operating Activities		(155,650	)		-			(155,650	)
Net Decrease in Cash		(155,650	)		-			(155,650	)
Cash – Beginning of the period		452,409			-			452,409
Cash – Ending of period	$	296,759		$	-		$	296,759
Supplemental Disclosure of Non-cash Financing Activities:
Change in value of ordinary shares subject to possible redemption	$	560,866		$	(560,866	)	$	-
Accretion of carrying value to redemption value	$	-		$	688,610		$	688,610

	As Previously						As
	Reported			Adjustments			Restated
Cash Flows from Operating Activities:
Net income	$	1,134,733		$	-		$	1,134,733
Adjustments to reconcile net income to net cash used in operating activities:								-
Interest earned on investment held in Trust Account		(1,382,661	)		-			(1,382,661	)
Change in fair value of warrant liabilities		(42,506	)		-			(42,506	)
Changes in current assets and current liabilities:
Prepaid assets		12,111			-			12,111
Accounts payable and accrued expense		(5,817	)		-			(5,817	)
Due to related parties		(2,379	)		-			(2,379	)
Net Cash Used in Operating Activities		(286,519	)		-			(286,519	)
Net Decrease in Cash		(286,519	)		-			(286,519	)
Cash – Beginning of the period		452,409			-			452,409
Cash – Ending of period	$	165,890		$	-		$	165,890
Supplemental Disclosure of Non-cash Financing Activities:
Change in value of ordinary shares subject to possible redemption	$	1,134,728		$	(1,134,728	)	$	-
Accretion of carrying value to redemption value	$	-		$	1,382,661		$	1,382,661

	As Previously						As
	Reported			Adjustments			Restated
Cash Flows from Operating Activities:
Net income	$	1,691,680		$	-		$	1,691,680
Adjustments to reconcile net income to net cash used in operating activities:								-
Interest earned on investment held in Trust Account		(1,999,894	)		-			(1,999,894	)
Change in fair value of warrant liabilities		(62,869	)		-			(62,869	)
Changes in current assets and current liabilities:
Prepaid assets		13,762			-			13,762
Accounts payable and accrued expense		(4,414	)		-			(4,414	)
Due to related parties		(2,379	)		-			(2,379	)
Net Cash Used in Operating Activities		(364,114	)		-			(364,114	)
Cash Flows from Financing Activities:
Proceeds from promissory note		1,148,800			-			1,148,800
Net Cash Provided by Financing Activities		1,148,800			-			1,148,800
Net Increase in Cash		784,686			-			784,686
Cash – Beginning of the period		452,409			-			452,409
Cash – Ending of period	$	1,237,095		$	-		$	1,237,095
Supplemental Disclosure of Non-cash Financing Activities:
Change in value of ordinary shares subject to possible redemption	$	1,691,675		$	(1,691,675	)	$	-
Accretion of carrying value to redemption value	$	-		$	1,999,894		$	1,999,894

	As Previously						As
	Reported			Adjustments			Restated
Cash Flows from Operating Activities:
Net income	$	402,558		$	-		$	402,558
Adjustments to reconcile net income to net cash used in operating activities:								-
Interest earned on investment held in Trust Account		(534,368	)		-			(534,368	)
Change in fair value of warrant liabilities		(16,418	)		-			(16,418	)
Changes in current assets and current liabilities:
Prepaid assets		(40,292	)		-			(40,292	)
Accounts payable and accrued expense		91,344			-			91,344
Net Cash Used in Operating Activities		(97,176	)		-			(97,176	)
Cash Flows from Investing Activities:
Purchase of investment held in Trust Account		(1,148,800	)		-			(1,148,800	)
Net Cash Used in Investing Activities		(1,148,800	)		-			(1,148,800	)
Cash Flows from Financing Activities:
Proceeds from promissory note – related party		780,000			-			780,000
Net Cash Provided by Financing Activities		780,000			-			780,000
Net Decrease in Cash		(465,976	)		-			(465,976	)
Cash – Beginning of the period		477,154			-			477,154
Cash – Ending of period	$	11,178		$	-		$	11,178
Supplemental Disclosure of Non-cash Financing Activities:
Change in value of ordinary shares subject to possible redemption	$	402,566		$	(402,566	)	$	-
Accretion of carrying value to redemption value	$	-			1,683,168		$	1,683,168

	As Previously						As
	Reported			Adjustments			Restated
Cash Flows from Operating Activities:
Net income	$	286,851		$	-		$	286,851
Adjustments to reconcile net income to net cash used in operating activities:								-
Interest earned on investment held in Trust Account		(558,639	)		-			(558,639	)
Change in fair value of warrant liabilities		(22,480	)		-			(22,480	)
Changes in current assets and current liabilities:
Prepaid assets		(27,677	)		-			(27,677	)
Accounts payable and accrued expense		142,875			-			142,875
Due to related party		100,005			-			100,005
Net Cash Used in Operating Activities		(79,065	)		-			(79,065	)
Cash Flows from Investing Activities:
Purchase of investment held in Trust Account		(1,268,800	)		-			(1,268,800	)
Cash withdrawn from Trust Account to pay redeeming shareholders		105,879,118			-			105,879,118
Net Cash Provided by Investing Activities		104,610,318			-			104,610,318
Cash Flows from Financing Activities:
Proceeds from promissory note – related party		780,000			-			780,000
Proceeds from promissory note		100,000			-			100,000
Redemption of ordinary shares		(105,879,118	)		-			(105,879,118	)
Net Cash Used in Financing Activities		(104,999,118	)		-			(104,999,118	)
Net Decrease in Cash		(467,865	)		-			(467,865	)
Cash – Beginning of the period		477,154			-			477,154
Cash – Ending of period	$	9,289		$	-		$	9,289
Supplemental Disclosure of Non-cash Financing Activities:
Change in value of ordinary shares subject to possible redemption	$	286,858		$	(286,858	)	$	-
Accretion of carrying value to redemption value	$	-		$	1,827,439		$	1,827,439

	As Previously						As
	Reported			Adjustments			Restated
Cash Flows from Operating Activities:
Net income	$	202,621		$	-		$	202,621
Adjustments to reconcile net income to net cash used in operating activities:								-
Interest earned on investment held in Trust Account		(559,019	)		-			(559,019	)
Change in fair value of warrant liabilities		(38,214	)		-			(38,214	)
Changes in current assets and current liabilities:
Prepaid assets		(11,052	)		-			(11,052	)
Accounts payable and accrued expense		173,905			-			173,905
Due to related party		205,000			-			205,000
Net Cash Used in Operating Activities		(26,759	)		-			(26,759	)
Cash Flows from Investing Activities:
Purchase of investment held in Trust Account		(1,448,800	)		-			(1,448,800	)
Cash withdrawn from Trust Account to pay redeeming shareholders		105,879,118			-			105,879,118
Net Cash Provided by Investing Activities		104,430,318			-			104,430,318
Cash Flows from Financing Activities:
Proceeds from promissory note – related party		780,000			-			780,000
Proceeds from promissory note		220,000			-			220,000
Redemption of ordinary shares		(105,879,118	)		-			(105,879,118	)
Net Cash Used in Financing Activities		(104,879,118	)		-			(104,879,118	)
Net Decrease in Cash		(475,559	)		-			(475,559	)
Cash – Beginning of the period		477,154			-			477,154
Cash – Ending of period	$	1,595		$	-		$	1,595
Supplemental Disclosure of Non-cash Financing Activities:
Change in value of ordinary shares subject to possible redemption	$	202,627		$	(202,627	)	$	-
Accretion of carrying value to redemption value	$	-		$	2,007,819		$	2,007,819